Quantcast

Latest Prostate cancer Stories

2014-04-21 23:05:06

Tissue diagnostics market includes instruments, reagents and kits used to determine the stage, prognosis, and treatment course of the disease; http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html. (PRWEB) April 21, 2014 The “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer...

2014-04-21 23:03:08

New research report “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends...

2014-04-20 23:01:14

A federal jury’s decision to award billions of dollars in damages to a bladder cancer patient who took Actos could mean that others in the same situation may also have a right to seek compensation. Raleigh, NC (PRWEB) April 20, 2014 Last week, the Osaka, Japan-based company that produces the diabetes drug Actos and their American marketing partner Eli Lilly were ordered to pay more than $9 billion because Takeda allegedly concealed cancer risks associated with its Actos diabetes drug....

2014-04-18 13:44:32

The presence of chronic inflammation in benign prostate tissue was associated with high-grade, or aggressive, prostate cancer, and this association was found even in those with low prostate-specific antigen (PSA) levels, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. An analysis of prostate tissue biopsies collected from some participants of the placebo arm of the Prostate Cancer Prevention...

2014-04-17 23:08:10

In the wake of a federal jury’s decision to award $9 billion to a man who developed bladder cancer after using the diabetes drug Actos, Cancer Monthly says patients who took Actos should recognize the symptoms of bladder cancer and protect their rights if they are diagnosed. Raleigh, NC (PRWEB) April 17, 2014 Cancer information site Cancer Monthly is advising Actos users to be aware of the symptoms of bladder cancer after a jury in the U.S. District Court for Western Louisiana concluded...

2014-04-17 12:29:51

LONDON, April 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:MediPoint: Biopsy Devices - US Analysis and Market Forecastshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/medipoint_biopsy_devices_us_analysis_market_forecasts.htmlMediPoint: Biopsy Devices - US Analysis and Market ForecastsSummaryCancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of...

2014-04-16 23:10:18

The Japanese drug maker that was recently ordered to pay $6 billion to a man who claimed that his bladder cancer diagnosis was caused by Actos, makes several other drugs with the same active ingredient. (PRWEB) April 16, 2014 The diabetes drug Actos has made news headlines this week after a jury decided that its manufacturer, Takeda, was responsible for causing bladder cancer in this case. But Actos is just one of several pioglitazone-containing drugs produced by Takeda and all of them...

2014-04-16 12:30:22

Advanced Tumor Modeling for Evaluation of Cancer Therapy Efficacy at the Cellular Level MENLO PARK, Calif., April 16, 2014 /PRNewswire/ -- SRI International has announced the availability of its PDCellX(TM) xenograft tumor model services for testing the activity of potential cancer therapeutics. PDCellX models provide clinically relevant information that allows researchers to evaluate the efficacy of cancer drug candidates in new models that go beyond traditional tumor xenograft...

2014-04-15 23:13:25

HERBTHEORY™ (formerly Sainthood Herbs), the maker of natural dietary supplements, is proud to announce nine exciting new products and a “new look” to its labels across its four main product categories recently on display at EXPO West. Irwindale, CA (PRWEB) April 15, 2014 HERBTHEORY™ (formerly Sainthood Herbs), the maker of natural dietary supplements, is proud to announce nine exciting new products and a “new look” to its labels across its four main product categories recently...

2014-04-15 23:09:00

The cancer information website Cancer Monthly says bladder cancer patients who took Actos should not wait to seek legal advice, despite drug maker’s plans to appeal a federal jury’s ruling. Raleigh, NC (PRWEB) April 15, 2014 The makers of the diabetes drug Actos say they will appeal last week’s award of $9 billion in punitive damages to a man who claims that Actos caused his bladder cancer, (1) (Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al, No....


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related